X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (8) 8
hematology, oncology and palliative medicine (8) 8
humans (8) 8
oncology (8) 8
female (7) 7
index medicus (7) 7
lung cancer, non-small cell (7) 7
lung neoplasms - drug therapy (7) 7
male (7) 7
middle aged (7) 7
adult (6) 6
aged (6) 6
cancer (6) 6
carcinoma, non-small-cell lung - drug therapy (6) 6
care and treatment (5) 5
lung neoplasms - pathology (5) 5
antineoplastic agents - therapeutic use (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
growth-factor receptor (4) 4
lung cancer (4) 4
metastasis (4) 4
mutation (4) 4
aged, 80 and over (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
cancer therapies (3) 3
disease-free survival (3) 3
gefitinib (3) 3
iii trial (3) 3
neoplasm staging (3) 3
oncology, experimental (3) 3
protein kinase inhibitors - therapeutic use (3) 3
research (3) 3
acquired-resistance (2) 2
analysis (2) 2
antibodies, monoclonal - administration & dosage (2) 2
brain metastases (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
clinical trials (2) 2
disease progression (2) 2
docetaxel (2) 2
erlotinib (2) 2
lung neoplasms - genetics (2) 2
nsclc (2) 2
pemetrexed (2) 2
pyrazoles - therapeutic use (2) 2
pyridines - therapeutic use (2) 2
quinazolines - therapeutic use (2) 2
response evaluation criteria in solid tumors (2) 2
survival (2) 2
tumors (2) 2
tyrosine (2) 2
activating mutations (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - secondary (1) 1
advanced nsclc (1) 1
advanced nsclc, observational study, chemotherapy, platin-based chemotherapy, pemtrexed, docetaxel, targeted therapy, erlotinib (1) 1
afatinib (1) 1
agents (1) 1
alanine (1) 1
alanine transaminase (1) 1
alanine transaminase - blood (1) 1
alectinib (1) 1
anaplastic lymphoma kinase (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
appreciation (1) 1
aspartate aminotransferase (1) 1
aspartate aminotransferases - blood (1) 1
benzimidazoles - administration & dosage (1) 1
benzimidazoles - adverse effects (1) 1
bevacizumab (1) 1
brazil (1) 1
carbazoles - therapeutic use (1) 1
carboplatin (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - secondary (1) 1
cardiovascular disease (1) 1
cell lung-cancer (1) 1
central nervous system (1) 1
central nervous system neoplasms - drug therapy (1) 1
central nervous system neoplasms - secondary (1) 1
cerebrovascular system (1) 1
cetuximab (1) 1
cisplatin - administration & dosage (1) 1
clinical trials as topic (1) 1
clinical-practice (1) 1
clinical-trials (1) 1
cns metastases (1) 1
combination (1) 1
comparative analysis (1) 1
crizotinib (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 5, pp. 528 - 538
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 874 - 886
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 38 - 47
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 328 - 337
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 82, pp. 27 - 33
Journal Article
Rivista d'Arte, ISSN 1122-0732, 01/1953, Volume 28, p. 161
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.